- ￥760 - 2550
- Sino Biological
- 北京
- HG19788-U
- 2025年08月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃ to -80℃
- 保质期：
3个月
- 英文名：
Human ALDH1A2 Gene ORF cDNA clone in cloning vector
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 规格：
1 Unit
| 货号: | 表达载体: |
| HG19788-U | pUC19 Vector |
| HG19788-ACGLN | pLV-C-GFPSpark |
| HG19788-UT | pCMV3-untagged |
Human ALDH1A2 Gene ORF cDNA clone in cloning vector产品信息
基因靶点：ALDH1A2
反应种属：Human
应用说明：
cDNA描述：Full length Clone DNA of Human aldehyde dehydrogenase 1 family member A2
| 货号： | HG19788-U |
| 产品名称： | Human ALDH1A2 Gene ORF cDNA clone in cloning vector |
| NCBI 参考序列号: | NM_001206897.1 |
| 序列长度: | 1269 |
| 表达载体: | pUC19 Vector |
| cDNA描述： | Full length Clone DNA of Human aldehyde dehydrogenase 1 family member A2 |
| 货号： | HG19788-ACGLN |
| 产品名称： | Human ALDH1A2 Gene Lentiviral ORF cDNA expression plasmid, C-GFPSpark tag |
| NCBI 参考序列号: | NM_001206897.1 |
| 序列长度: | 1269 |
| 表达载体: | pLV-C-GFPSpark |
| cDNA描述： | Full length Clone DNA of Homo sapiens aldehyde dehydrogenase 1 family member A2 |
| 货号： | HG19788-UT |
| 产品名称： | Human ALDH1A2 Gene ORF cDNA clone expression plasmid |
| NCBI 参考序列号: | NM_001206897.1 |
| 序列长度: | 1269 |
| 表达载体: | pCMV3-untagged |
| cDNA描述： | Full length Clone DNA of Human aldehyde dehydrogenase 1 family member A2 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Using the DFCI Gene Index Databases for Biological Discovery
. Genet. 10:369‐371. Cariaso, M., Folta, P., Wagner, M., Kuczmarski, T., and Lennon, G. 1999. IMAGEne I: Clustering and ranking of I.M.A.G.E. cDNA clones corresponding to known
Introduction of human 14-3-3 proteins
whose members have been shown to activate tyrosine and tryptophan hydroxylases,inhibit protein kinase C and possess phospholipase A2 activity in vitro.We have isolated and analyzed a 14-3-3 protein cDNA clone (H14-3-3)from a human fetal brain cDNA library
Antibody Humanization by CDR Grafting
of antibody therapeutics in the 1980s, when the major obstacle was the human anti-murine antibody (HAMA) response (1 , 2 ). The HAMA response occurred in up to 50% of patients upon the administration of murine hybridoma-derived antibodies (3 ) and severely
技术资料暂无技术资料 索取技术资料
